Clinical features and renal outcome in lupus patients with diffuse crescentic glomerulonephritis

Rheumatology International

Volumn 30, Issue 1, 2009, Pages 45-49

  Tang, Zheng ^a,b   Wang, Zhen ^b   Zhang, Hai Tao ^a,b   Hu, Wei Xin ^a,b   Zeng, Cai Hong ^a,b   Chen, Hui Ping ^a,b   Liu, Zhi Hong ^a,b   Li, Lei Shi ^a,b  

^a JINLING HOSPITAL   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Diffuse crescent formation; Lupus nephritis; Renal outcomes

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; HEMOGLOBIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TRIPTERYGIUM WILFORDII EXTRACT;

ADULT; ANEMIA; ARTICLE; CLINICAL FEATURE; COMPLEMENT BLOOD LEVEL; DIFFUSE CRESCENTIC GLOMERULONEPHRITIS; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEMATURIA; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; OLIGURIA; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RETREATMENT; SURVIVAL; UREMIA;

ADOLESCENT; ADULT; ANEMIA; BIOPSY; CHINA; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HEMATURIA; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; NEPHROTIC SYNDROME; PROTEINURIA; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71349084161     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0908-5     Document Type: Article

References (20)

1. Falk R, Jennette C, Nachman P (2000) Rapidly progressive glomerulonephritis and crescentic glomerulonephritis. In: Brenner BM (ed) Brenner & Recto's the kidney, vol II, 6th edn. WB Sunders Company, Philadelphia, pp 1313-1321
2. R Zent R Van Zyl Smit M Duffield M Cassidy 1994 Crescentic nephritis at Groote Schuur Hospital, South Africa-not a benign disease Clin Nephrol 42 22 29 1:STN:280:DyaK2M%2FgvVCgsg%3D%3D 7923962
3. W Couser 1988 Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy Am J Kidney Dis 11 449 464 1:STN:280:DyaL1c3jvVGhtA%3D%3D 3287904
4. K Andrassy S Kuster R Waldherr E Ritz 1991 Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course Nephron 59 206 212 10.1159/000186552 1:STN:280:DyaK38%2Fms1SltQ%3D%3D 1956482
5. Z Tang Y Wu Q Wang, et al. 2003 Clinical spectrum of diffuse crescentic glomerulonephritis in Chinese patients Chin Med J (Engl) 116 1737 1740
6. H Chen Z Tang C Zeng, et al. 2003 Pathological demography of native patients in a nephrology center in China Chin Med J (Engl) 116 1377 1381
7. Z Tang L Li J Zhang, et al. 1992 Methyoprednisone plus cyclophosphomide pulse therapy on patients with severe glomerulonephritis Jinling Hosp Bull 2 197 200
8. D Boumpas H Austin 3rd E Vaughn, et al. 1992 Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis Lancet 340 741 745 10.1016/0140-6736(92)92292-N 10.1016/0140-6736(92) 92292-N 1:STN:280:DyaK38vgvVentQ%3D%3D 1356175
9. C Najafi S Korbet E Lewis M Schwartz M Reichlin J Evans 2001 Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis Kidney Int 59 2156 2163 1:STN:280: DC%2BD3M3psF2qug%3D%3D 11380817
10. G Yao WX Hu ZH Liu, et al. 2002 The significance of renal vascular lesion in patients with proliferative lupus nephritits Chin J Nephrol Dial Transplant 11 211 217
11. E Ginzler E Sharon H Diamond D Kaplan 1975 Long-term maintenance therapy with azathioprine in systemic lupus erythematosus Arthritis Rheum 18 27 34 10.1002/art.1780180106 10.1002/art.1780180106 1:STN:280:DyaE2M7gvV2ntQ%3D%3D 1115745
12. J Donadio Jr K Holley R Ferguson D Ilstrup 1978 Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide N Engl J Med 299 1151 1155 309095
13. J Cameron 1993 What is the role of long-term cytotoxic agents in the treatment of lupus nephritis J Nephrol 6 172 176
14. H Austin 3rd J Klippel J Balow, et al. 1986 Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs N Engl J Med 314 614 619 3511372
15. A Steinberg S Steinberg 1991 Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only Arthritis Rheum 34 945 950 10.1002/art.1780340803 10.1002/art.1780340803 1:STN:280:DyaK3MzhsFKhug%3D%3D 1859488
16. Z Tang W XU 1992 Effects of cyclophosphamide intravenously pulse therapy on patients with lupus nephritis J Chin Nephrol 8 257 260
17. V Bansal J Beto 1997 Treatment of lupus nephritis: a meta-analysis of clinical trials Am J Kidney Dis 29 193 199 10.1016/S0272-6386(97)90029-9 10.1016/S0272-6386(97)90029-9 1:STN:280:DyaK2s7mvFSrsA%3D%3D 9016889
18. WX Hu ZH Liu HP Chen Z Tang LS Li 1998 Mycophenolate mofetil(mmf) treatment for refractory severe lupus nephritis Chin J Nephrol Dial Transplant 7 511 515
19. MA Dooley FG Cosio PH Nachman, et al. 1999 Mycophenolate mofetil therapy in lupus nephritis: clinical observations J Am Soc Nephrol 10 833 839 1:CAS:528:DyaK1MXitl2kur4%3D 10203368
20. WX Hu HP Chen Z Tang, et al. 2000 Clinical and pathological study of mycophenolate mofetil(mmf)therapy versus intermittent cyclophosphamide pulse treatment in severe diffuse proliferative lupus nephritis(dpln) Chin J Nephrol Dial Transplant 9 3 8